Average Co-Inventor Count = 3.79
ph-index = 34
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Samumed, LLC (96 from 115 patents)
2. Biosplice Therapeutics, Inc. (9 from 18 patents)
3. Targegen, Inc. (8 from 13 patents)
4. The Scripps Research Institute (3 from 1,184 patents)
5. Endeavor Biomedicines, Inc. (3 from 3 patents)
6. Leland Stanford Junior University (2 from 5,253 patents)
7. Impact Biomedicines, Inc. (1 from 2 patents)
120 patents:
1. 12295954 - Methods of treating fibrosis
2. 12213974 - Methods of treating fibrosis
3. 11839679 - Gamma-diketones for treatment and prevention of aging skin and wrinkles
4. 11780823 - Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitors
5. 11697649 - Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof
6. 11684615 - Methods of using indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibitors
7. 11673885 - γ-diketones as Wnt/β-catenin signaling pathway activators
8. 11667632 - 2-(1H-indazol-3-yl)-3H-imidazo[4,5-C]pyridines and their anti-inflammatory uses thereof
9. 11628167 - Method of treating fibrosis
10. 11560378 - Treatment of osteoarthritis
11. 11400092 - Methods of treating myeloproliferative disorders
12. 11077046 - Gamma-diketones for treatment and prevention of aging skin and wrinkles
13. 11066388 - Indazole-3-carboxamides and their use as WNT/B-catenin signaling pathway inhibitors
14. 11034682 - Gamma-diketones as wnt/β-catenin signaling pathway activators
15. 10947228 - Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof